Literature DB >> 9786377

The rational clinical examination. Is this patient having a myocardial infarction?

A A Panju1, B R Hemmelgarn, G H Guyatt, D L Simel.   

Abstract

When faced with a patient with acute chest pain, clinicians must distinguish myocardial infarction (MI) from all other causes of acute chest pain. If MI is suspected, current therapeutic practice includes deciding whether to administer thrombolysis or primary percutaneous transluminal coronary angioplasty and whether to admit patients to a coronary care unit. The former decision is based on electrocardiographic (ECG) changes, including ST-segment elevation or left bundle-branch block, the latter on the likelihood of the patient's having unstable high-risk ischemia or MI without ECG changes. Despite advances in investigative modalities, a focused history and physical examination followed by an ECG remain the key tools for the diagnosis of MI. The most powerful features that increase the probability of MI, and their associated likelihood ratios (LRs), are new ST-segment elevation (LR range, 5.7-53.9); new Q wave (LR range, 5.3-24.8); chest pain radiating to both the left and right arm simultaneously (LR, 7.1); presence of a third heart sound (LR, 3.2); and hypotension (LR, 3.1). The most powerful features that decrease the probability of MI are a normal ECG result (LR range, 0.1-0.3), pleuritic chest pain (LR, 0.2), chest pain reproduced by palpation (LR range, 0.2-0.4), sharp or stabbing chest pain (LR, 0.3), and positional chest pain (LR, 0.3). Computer-derived algorithms that depend on clinical examination and ECG findings might improve the classification of patients according to the probability that an MI is causing their chest pain.

Entities:  

Mesh:

Year:  1998        PMID: 9786377     DOI: 10.1001/jama.280.14.1256

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  39 in total

1.  What tests for suspected myocardial infarction? Serum cardiac troponin I or creatine kinase?

Authors:  A AlKhenizan; M F Evans
Journal:  Can Fam Physician       Date:  2000-08       Impact factor: 3.275

2.  Chest pain units.

Authors:  Mike Clancy
Journal:  BMJ       Date:  2002-07-20

Review 3.  The ABC of community emergency care: chest pain.

Authors:  C Laird; P Driscoll; J Wardrope
Journal:  Emerg Med J       Date:  2004-03       Impact factor: 2.740

4.  Identification of patients with evolving coronary syndromes by using statistical models with data from the time of presentation.

Authors:  R L Kennedy; R F Harrison
Journal:  Heart       Date:  2005-06-06       Impact factor: 5.994

5.  How should diagnostic tests be evaluated in glaucoma?

Authors:  Felipe A Medeiros
Journal:  Br J Ophthalmol       Date:  2007-03       Impact factor: 4.638

6.  A prospective, observational study of a chest pain observation unit in a British hospital.

Authors:  S W Goodacre; F M Morris; S Campbell; J Arnold; K Angelini
Journal:  Emerg Med J       Date:  2002-03       Impact factor: 2.740

7.  Is a chest pain observation unit likely to be cost saving in a British hospital?

Authors:  S Goodacre; F Morris; J Arnold; K Angelini
Journal:  Emerg Med J       Date:  2001-01       Impact factor: 2.740

8.  Acute chest pain--identification of patients at low risk for coronary events. The impact of symptoms, medical history and risk factors.

Authors:  Martin Schillinger; Gottfried Sodeck; Giora Meron; Karin Janata; Mariam Nikfardjam; Fritz Rauscha; Anton N Laggner; Hans Domanovits
Journal:  Wien Klin Wochenschr       Date:  2004-02-16       Impact factor: 1.704

9.  Ruling out coronary heart disease in primary care patients with chest pain: a clinical prediction score.

Authors:  Baris Gencer; Paul Vaucher; Lilli Herzig; François Verdon; Christiane Ruffieux; Stefan Bösner; Bernard Burnand; Thomas Bischoff; Norbert Donner-Banzhoff; Bernard Favrat
Journal:  BMC Med       Date:  2010-01-21       Impact factor: 8.775

10.  GPs' reasons for referral of patients with chest pain: a qualitative study.

Authors:  Rudi Bruyninckx; Ann Van den Bruel; Karin Hannes; Frank Buntinx; Bert Aertgeerts
Journal:  BMC Fam Pract       Date:  2009-07-31       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.